Chronic diarrhea medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 30: Line 30:
**[[Small bowel bacterial overgrowth syndrome#Treatment|Small bowel bacterial overgrowth syndrome]]
**[[Small bowel bacterial overgrowth syndrome#Treatment|Small bowel bacterial overgrowth syndrome]]


Below are some of the [[drugs]] that can be used in the symptomatic treatment of chronic diarrhea and some of their mechanisms of actions. Some [[drugs]] have numerous mechanisms of action and can thus be found under more than one sections. It is important to know that these drugs are used for the symptomatic treatment of chronic diarrhea. In order to appropriately treat chronic diarrhea, the underlying cause of the disease must be identified.<ref name="pmid7605866">{{cite journal| author=Schiller LR| title=Review article: anti-diarrhoeal pharmacology and therapeutics. | journal=Aliment Pharmacol Ther | year= 1995 | volume= 9 | issue= 2 | pages= 87-106 | pmid=7605866 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7605866  }} </ref>
Below are some of the [[drugs]] that can be used in the symptomatic treatment of chronic [[diarrhea]] and some of their mechanisms of actions. Some [[drugs]] have numerous mechanisms of action and can thus be found under more than one sections. It is important to know that these [[drugs]] are used for the [[symptomatic]] treatment of chronic [[diarrhea]]. In order to appropriately treat chronic [[diarrhea]], the underlying cause of the [[disease]] must be identified.<ref name="pmid7605866">{{cite journal| author=Schiller LR| title=Review article: anti-diarrhoeal pharmacology and therapeutics. | journal=Aliment Pharmacol Ther | year= 1995 | volume= 9 | issue= 2 | pages= 87-106 | pmid=7605866 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7605866  }} </ref>


'''Inhibitors of intestinal transit time'''
'''Inhibitors of intestinal transit time'''

Revision as of 18:20, 28 July 2017

Chronic diarrhea Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic diarrhea from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

Antidiarrheal drugs can be broadly defined as agents that minimize the symptoms of diarrhea by improving stool consistency, reducing stool frequency, or reducing stool weight. Chronic diarrhea is a common symptom of many conditions, in order to appropriately treat chronic diarrhea, the underlying causes must be identified and treated and in most cases the chronic diarrhea will resolve.[1]

Medical Therapy

For the treatment of the most common causes of chronic diarrhea, please click below:

Below are some of the drugs that can be used in the symptomatic treatment of chronic diarrhea and some of their mechanisms of actions. Some drugs have numerous mechanisms of action and can thus be found under more than one sections. It is important to know that these drugs are used for the symptomatic treatment of chronic diarrhea. In order to appropriately treat chronic diarrhea, the underlying cause of the disease must be identified.[1]

Inhibitors of intestinal transit time

Pro-absorptive agents

Antisecretory drugs

Intraluminal agents

References

  1. 1.0 1.1 Schiller LR (1995). "Review article: anti-diarrhoeal pharmacology and therapeutics". Aliment Pharmacol Ther. 9 (2): 87–106. PMID 7605866.


Template:WH Template:WS